These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10309094)

  • 1. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
    Blackstone M; Hauser LD
    Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
    [No Abstract]   [Full Text] [Related]  

  • 2. Analyzing captial investments.
    Gray SP
    Hosp Purch Manage; 1980 Sep; 5(9):3-7. PubMed ID: 10309238
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and time required to add potassium chloride to large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
    Turco SJ
    Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
    [No Abstract]   [Full Text] [Related]  

  • 6. Calculation of product waste in i.v. admixture programs.
    Vogel DP; Eck TA; Witte KW
    Am J Hosp Pharm; 1986 Apr; 43(4):952-3. PubMed ID: 3706344
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality assurance in I.V. admixture programs.
    Turco SJ
    Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
    [No Abstract]   [Full Text] [Related]  

  • 8. Documenting i.v. admixture product waste.
    Waller DJ
    Am J Hosp Pharm; 1986 Aug; 43(8):1914-5. PubMed ID: 3752129
    [No Abstract]   [Full Text] [Related]  

  • 9. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ; Newton RW; Leduc DT
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost, motion, and time studies comparing a new cephalosporin admixture system.
    Turco SJ
    Hosp Pharm; 1982 Dec; 17(12):653-8. PubMed ID: 10257925
    [No Abstract]   [Full Text] [Related]  

  • 12. Purchasing premixed products.
    Geberbauer CW
    J Healthc Mater Manage; 1988; 6(2):40, 42, 44-5. PubMed ID: 10286278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high cost of customization: compounding drugs.
    Cohen MR
    Hosp Pharm; 1991 Apr; 26(4):384-5. PubMed ID: 10113578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling admixture waste through pharmacist monitoring.
    Adachi WD; Endo AY; Tanaka JY
    Am J Hosp Pharm; 1984 May; 41(5):883. PubMed ID: 6731449
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation and cost analysis of a syringe pump system for intermittent i.v. drug delivery.
    Colangelo A; Clark ST; Janousek JP
    Am J Hosp Pharm; 1985 Mar; 42(3):581-4. PubMed ID: 3985021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 19. Inadequate medical order writing and delivery: a cause of unnecessary hospital costs.
    Larson EB; Dowell S; Scott DH
    QRB Qual Rev Bull; 1984 Nov; 10(11):353-5. PubMed ID: 6441138
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of a freeze-microwave thaw technique to central admixture services.
    Ausman RK; Holmes CJ; Walter CW; Kundsin RB
    Drug Intell Clin Pharm; 1980 Apr; 14(4):284-7. PubMed ID: 10247135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.